AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fagron N.V.

AGM Information May 15, 2018

3949_iss_2018-05-15_8c054dd9-1509-4b17-9488-5f1beacfdef9.pdf

AGM Information

Open in Viewer

Opens in native device viewer

Nazareth (Belgium) / Rotterdam (The Netherlands), 15 May 2018 Regulated information

Fagron announces today that the annual general meeting of shareholders and the extraordinary shareholders meeting, both held on 14 May 2018, have adopted all proposed resolutions.

The meeting approved, amongst other things, the 2017 financial statements and declared a dividend of € 0.10 per share for the year 2017. The shareholders have also discharged the directors and the statutory auditor who were active during the 2017 financial year. The meeting also approved the co-optation by the board of directors of Management Deprez BVBA, permanently represented by Veerle Deprez, as an independent nonexecutive director and the co-optation of Rafael Padilla as an executive director. Furthermore, the meeting decided to reappoint Rafael Padilla and Karin de Jong as executive directors for a period of four years. Management Deprez BVBA, permanently represented by Veerle Deprez, was reappointed as an independent non-executive director for a period of four years.

Fagron is paying a gross dividend of € 0.10 per share (coupon number 10). This is a net dividend of € 0.07 per share; being the gross dividend less 30% Belgian dividend withholding tax.

The calendar is as follows: May Ex-dividend date May Record date May Dividend available for payment

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

For more information: Constantijn van Rietschoten Chief Communications Officer Tel. +31 (0)6 53 69 15 85 [email protected]

Fagron profile

Fagron is a leading global company active in pharmaceutical compounding and focused on delivering personalized pharmaceutical care to hospitals, pharmacies, clinics and patients in 34 countries around the world.

The Belgian company Fagron NV is located in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam (stock market code 'FAGR'). The operational activities of Fagron are driven by the Dutch company Fagron BV. The head office of Fagron BV is located in Rotterdam.

Talk to a Data Expert

Have a question? We'll get back to you promptly.